The Patent Doc blog has begun to examine the contents of various amicus briefs filed with the Court in connection with the Myriad case. As can be expected, there a lot of passion on both sides of the question of whether "an isolated strand of genomic DNA" can be patent eligible or not. Needless to say, it has been eligible for 30+ years but the lower court Myriad ruling turned that on its head.
The Supreme Court is now asking for arguments on the matter in lieu of its recent rulings in Mayo v. Prometheus. Brief filers are of course lining up on both sdes and 23 amicus filings have been received. The two briefs discussed here come from the Intellectual Property Owners Association (IPO) and the US Government -- the former pro-patent eligibility and the latter taking the con side.
[Also, here is a link to USPTO Interim Guidance in lieu of Prometheus].
Posted by Bruce Lehr Jul 11th 2012.